Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siteng Chen

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
American Journal of Cancer Research|November 9, 2020
Ubiquitin ligase KLHL2 promotes the degradation and ubiquitination of ARHGEF7 protein to suppress renal cell carcinoma progressionEncheng Zhang, Xiao Dong, Siteng Chen, et al.
Journal of Clinical Medicine|December 23, 2022
Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell CarcinomaTuanjie Guo, Jian Zhang, Zhihao Yuan, et al.
International Journal of Surgery (London, England)|March 6, 2024
Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort studySiteng Chen, Feng Gao, Tuanjie Guo, et al.
Frontiers in Cell and Developmental Biology|February 8, 2021
A Novel m<sup>6</sup>A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell CarcinomaSiteng Chen, Ning Zhang, Encheng Zhang, et al.
British Journal of Cancer|November 26, 2021
Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinomaSiteng Chen, Liren Jiang, Feng Gao, et al.
British Journal of Cancer|May 3, 2023
Deep learning-based pathology signature could reveal lymph node status and act as a novel prognostic marker across multiple cancer typesSiteng Chen, Jinxi Xiang, Xiyue Wang, et al.
NPJ Digital Medicine|July 13, 2026
Deep learning-based CD8<sup>+</sup> T cell model for predicting prognosis and‌ targeted immunotherapy benefit in ccRCCSiteng Chen, Ning Zhang, Liren Jiang, et al.
Genes|April 23, 2022
Lactic Acid Metabolism and Transporter Related Three Genes Predict the Prognosis of Patients with Clear Cell Renal Cell CarcinomaTuanjie Guo, Jian Zhang, Tao Wang, et al.
BMC Cancer|January 4, 2022
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinomaSiteng Chen, Encheng Zhang, Tuanjie Guo, et al.
Precision Clinical Medicine|March 6, 2023
Integrative analysis of ferroptosis regulators for clinical prognosis based on deep learning and potential chemotherapy sensitivity of prostate cancerTuanjie Guo, Zhihao Yuan, Tao Wang, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
American Journal of Cancer Research|November 9, 2020
Ubiquitin ligase KLHL2 promotes the degradation and ubiquitination of ARHGEF7 protein to suppress renal cell carcinoma progressionEncheng Zhang, Xiao Dong, Siteng Chen, et al.
Journal of Clinical Medicine|December 23, 2022
Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell CarcinomaTuanjie Guo, Jian Zhang, Zhihao Yuan, et al.
International Journal of Surgery (London, England)|March 6, 2024
Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort studySiteng Chen, Feng Gao, Tuanjie Guo, et al.
Frontiers in Cell and Developmental Biology|February 8, 2021
A Novel m<sup>6</sup>A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell CarcinomaSiteng Chen, Ning Zhang, Encheng Zhang, et al.
British Journal of Cancer|November 26, 2021
Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinomaSiteng Chen, Liren Jiang, Feng Gao, et al.
British Journal of Cancer|May 3, 2023
Deep learning-based pathology signature could reveal lymph node status and act as a novel prognostic marker across multiple cancer typesSiteng Chen, Jinxi Xiang, Xiyue Wang, et al.
NPJ Digital Medicine|July 13, 2026
Deep learning-based CD8<sup>+</sup> T cell model for predicting prognosis and‌ targeted immunotherapy benefit in ccRCCSiteng Chen, Ning Zhang, Liren Jiang, et al.
Genes|April 23, 2022
Lactic Acid Metabolism and Transporter Related Three Genes Predict the Prognosis of Patients with Clear Cell Renal Cell CarcinomaTuanjie Guo, Jian Zhang, Tao Wang, et al.
BMC Cancer|January 4, 2022
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinomaSiteng Chen, Encheng Zhang, Tuanjie Guo, et al.
Precision Clinical Medicine|March 6, 2023
Integrative analysis of ferroptosis regulators for clinical prognosis based on deep learning and potential chemotherapy sensitivity of prostate cancerTuanjie Guo, Zhihao Yuan, Tao Wang, et al.
Pageof 5